Ceronapril

Overview of the drug Ceronapril

Ceronapril

Overview

Ceronapril is a pharmaceutical drug that belongs to the class of angiotensin-converting enzyme inhibitors (ACE inhibitors). It is primarily used in the treatment of hypertension and congestive heart failure. Ceronapril works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing blood pressure and decreasing the workload on the heart.

Mechanism of Action

Ceronapril inhibits the angiotensin-converting enzyme (ACE), which is responsible for the conversion of angiotensin I to angiotensin II. Angiotensin II is a hormone that causes blood vessels to constrict, leading to increased blood pressure. By blocking this conversion, Ceronapril causes vasodilation, which lowers blood pressure and improves blood flow.

Pharmacokinetics

Ceronapril is administered orally and is absorbed through the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys. The drug has a half-life that allows for once-daily dosing, making it convenient for patients to use.

Clinical Uses

Ceronapril is indicated for the treatment of:

• Hypertension: By lowering blood pressure, Ceronapril helps prevent complications such as stroke, myocardial infarction, and kidney failure.
• Congestive heart failure: It reduces the symptoms of heart failure by decreasing the workload on the heart and improving cardiac output.

Side Effects

Common side effects of Ceronapril include:

• Cough
• Hyperkalemia
• Dizziness
• Fatigue

Less common but serious side effects may include:

• Angioedema
• Renal impairment

Contraindications

Ceronapril is contraindicated in patients with:

• History of angioedema related to previous ACE inhibitor therapy
• Pregnancy: Due to the risk of fetal toxicity
• Severe renal impairment

Interactions

Ceronapril may interact with other medications, including:

• Diuretics: May enhance the hypotensive effect
• Potassium supplements or potassium-sparing diuretics: May increase the risk of hyperkalemia
• Nonsteroidal anti-inflammatory drugs (NSAIDs): May reduce the antihypertensive effect

Image

Chemical structure of Ceronapril

Related pages

• ACE inhibitors
• Hypertension
• Congestive heart failure